Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain
Internal Medicine
Diabetes & Obesity Research Priority Area
Markey Cancer Center / Cancer Research Priority Initiative
Translational Oncology Research Program
UNITE Research Priority Area
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Glycoprotein Gp 130
100%
Biological Marker
100%
Pancreatitis
100%
Chronic Pancreatitis
100%
Immunoassay
20%
Preclinical Study
20%
Prospective Cohort Study
20%
Abdominal Pain
20%
Interleukin 6
20%
Biochemistry, Genetics and Molecular Biology
Prospective Cohort Study
100%
Preclinical Study
100%
Interleukin 6
100%
Immunoassay
100%
Immunology and Microbiology
Pancreatitis
100%
Glycoprotein Gp 130
100%
Preclinical Study
16%
Immunoassay
16%
Interleukin 6
16%
Neuroscience
Glycoprotein Gp 130
100%
Interleukin 6
25%
Immunoassay
25%